What changed in this filing

/stocks — the workspaceLOADING

Item 1. Business

2025-03-13 compared with 2024-02-21 · 129 added, 120 removed, 105 unchanged (70% of the section changed)

We have developed and are commercializing products for managing animal pest populations, initially rat populations, through fertility control.

We currently have two product lines of fertility control products:

ContraPest and Evolve.

As far back as we can trace, rats have been foe to mankind.

Posing threats to human and animal health, food security, and infrastructure around the world, we have spent centuries trying to solve the problem.

Rats carry or can spread at least 35 diseases, globally posing a dangerous risk to public health and safety and agriculture.

We have developed and are commercializing products for managing animal pest populations through fertility control.

Our current products focus on rat and mouse populations, and are known as:

ContraPest, Evolve Rat, and Evolve Mouse.

As far back as we can trace, rodents - and in particular rats - have been foes to mankind.

Rodents pose threats to human and animal health, food security and infrastructure around the world, and we have spent centuries trying to mitigate the problems associated with these pests.

Rodents are known to be reservoir hosts for at least 60 zoonotic diseases and the potential transmission of these diseases creates a global risk to public health and safety, as well as agriculture.

Through consumption and contamination, rats destroy at least 20% of the global stored food supply every year.

Additionally, rats cause over $27 billion in damage to public and private infrastructure annually in the United States alone by burrowing beneath foundations, as well as gnawing on electrical wiring, insulation, fire proofing systems, electronics and computer equipment.

Over the centuries, the most prevalent response to rat infestations has been to try to eliminate them through the use of lethal tools such as traps and rodenticides.

However, there are growing concerns about secondary exposure and bioaccumulation of rodenticides.

While some of these challenges are of recent concern, the efficacy of the response to rat infestations has always been limited by the rat’s extraordinary reproductive rate.

ContraPest®, our initial product, is a novel liquid bait in the pest control industry, containing the active ingredients 4-vinylcyclohexene diepoxide (“VCD”) and triptolide.

ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions of the rat population.

ContraPest is a highly palatable liquid formulation that reduces fertility in both male and female rats.

The high fat content and sweet taste of ContraPest promotes sustained consumption even when other sought-after food sources are present.

In both field and laboratory settings, consumption of ContraPest occurs even in the presence of abundant water sources and plentiful food choices, including animal feed, trash and other options.

Additionally, ContraPest does not cause illness in rats, and, therefore, it does not change behavior or result in bait aversion.

Accordingly, ContraPest offers a new tool used in coordination with rodenticides as part of an integrated pest management program.

Additionally, ContraPest can be successfully used as an alternative to traditional rodenticides altogether, an important option in the increasing number of jurisdictions that are restricting the use of second-generation anti-coagulant products.

The registration process with the EPA for ContraPest began on August 23, 2015.

On August 2, 2016, the EPA granted an unconditional registration for ContraPest as a Restricted Use Product (“RUP”), due to the need for applicator expertise for deployment.

On October 18, 2018, the EPA approved the removal of the RUP designation and was reclassified as a general-use pesticide.

ContraPest is registered in all 50 states, 49 of which have approved the removal of the RUP designation, as well as the District of Columbia and five major U.S.

In certain cases, our registrations are conditional and require completion of testing.

We continue to actively seek to comply with these requirements.

On March 10, 2022, the EPA granted a sub-label for ContraPest allowing for an alternative delivery system in a hanging bait station designed to target roof rat habitats and infestations, currently marketed as Elevate Bait System™.

We are continuously enhancing ContraPest to align with the unique needs and environments of our customers in our target verticals while simultaneously pursuing regulatory approvals and amendments to the existing U.S.

Additionally, rats cause over $27 billion in damage to public and private infrastructure annually in the United States alone by burrowing beneath foundations and gnawing on electrical wiring, insulation, fire-proofing systems and equipment.

Over the centuries, the most prevalent response to rodent infestations has been an attempt to eliminate them through the use of lethal tools such as traps and rodenticides.

However, there are growing concerns about the environmental and ecological impact of rodenticides due to secondary exposure and bioaccumulation, including a push for safer and more humane products as consumer awareness increases.

While some of these challenges are of recent concern, the efficacy of how rodent infestations respond has always been limited by their extraordinary reproductive rate.

ContraPest, our initial product, is a liquid bait, containing the active ingredients 4-vinylcyclohexene diepoxide (“VCD”) and triptolide.

ContraPest targets the reproductive systems of both male and female rats, is a highly palatable formulation, does not cause illness or changed behavior in rats, and leads to significant reductions in fertility and rat populations.

Accordingly, ContraPest is an additional tool to use as part of an IPM program.

On August 2, 2016, the EPA granted an unconditional registration for ContraPest as a Restricted Use Product (“RUP”), requiring purchase or application oversight by a licensed professional.

On October 18, 2018, the EPA approved the removal of the RUP designation and ContraPest was reclassified as a general-use pesticide.

To date, ContraPest is registered in all 50 states (49 states and the District of Columbia have approved the RUP designation) and two major U.S.

territories, Puerto Rico and the U.S.

Virgin Islands.

On March 10, 2022, the EPA granted a sub-label for ContraPest allowing for an alternative delivery system in a hanging bait station.

This sub-label is marketed as Elevate Bait System™ and was designed to target roof rat habitats and infestations.

The Evolve product line, which began in the form of Evolve Rat, launched in January 2024, and is currently our lead product.

Evolve Rat is a soft bait product that is novel to the pest control industry and contains the active ingredient, cottonseed oil.

Evolve Rat reduces fertility in both male and female rats.

Additionally, its palatable formulation produces high acceptance for sustained consumption even when other sought-after food sources are present.

, Evolve Rat does not cause illness in rats and, therefore, it does not change behavior or result in bait aversion.

By targeting the

reproductive systems of both male and female rats, and with palatability promoting continued consumption, the use of Evolve can lead to sustained reductions of the rat population.

Evolve Rat meets the EPA’s minimum risk pesticide conditions under FIFRA, Section 25(b).

Due to its classification, Evolve is exempt from federal registration because it poses little to no risk to human health and the environment.

Evolve is also made from food ingredients with tolerance exemptions for both food and nonfood applications, which allows it to be used in agricultural application.

There are 10 states that accept the federal exemption for pesticide registration and require no additional determination or approval.

In states that do not accept the federal exemption, we must obtain registration from the various state regulatory agencies.

To date, we are authorized to sell Evolve in 48 states.

In May 2024, we launched Evolve Mouse, our latest iteration of the Evolve product line.

Evolve Mouse is a modified version of our soft bait technology and contains the active ingredient, cottonseed oil.

Evolve Mouse limits reproduction of male and female mice and is also considered a minimum risk pesticide under the EPA’s FIFRA, Section 25(b).

To date, we are authorized to sell Evolve Mouse in 35 states.

We are continuously enhancing ContraPest and Evolve to align with the unique needs and environments of our customers in our target verticals while simultaneously pursuing regulatory approvals and amendments to our existing U.S.

registration to broaden its use and marketability.

When regulatory and financial conditions permit, we will seek regulatory approval for additional jurisdictions beyond the United States.

Evolve, our second product, is a novel soft bait product in the pest control industry.

Evolve targets the reproductive systems of both male and female rats, which can lead to sustained reductions of the rat population.

Evolve is a soft bait

containing the active ingredient cottonseed oil.

Evolve limits the reproduction of male and female rats within one to two breeding cycles following consumption.

Evolve has not been registered by the EPA.

Evolve qualifies for exemption from registration as a minimum risk pesticide under FIFRA Section 25(b).

All applicable requirements for registration, manufacturing, selling, or distributing into designated states and territories have been met.

There are 10 states that accept the federal exemption for pesticide registration with the respective state.

For those states that do not accept the federal exemption, we began the registration process for those states in October 2023.

To date, we are authorized to sell Evolve in 30 states.

We were incorporated in the state of Nevada in July 2004.

On November 12, 2015, we reincorporated in the state of Delaware.

Our corporate headquarters and manufacturing site are in Phoenix, Arizona.

On December 8, 2016, we went public and are currently traded on the Nasdaq Capital Market (“Nasdaq”) under the symbol SNES.

In November 2023, we amended our amended and restated certificate of incorporation to effect a 1-for-12 reverse split of our issued and outstanding shares of common stock.

The accompanying financial statements and notes thereto give retrospective effect to the reverse stock split for all periods presented.

All issued and outstanding common stock, options and warrants exercisable for common stock, restricted stock units, and per share amounts contained in our financial statements have been retrospectively adjusted.

Current Challenges in Pest Control Methodologies

Two base rats, a male and female, can produce 15,000 descendants in approximately 12 months.

Lethal control measures such as traps and rodenticides are often at the forefront of rat control programs, but this reproduction rate, intelligence, and genetic resistance to the active ingredients in rodenticides can negatively impact results of traditional mitigation efforts.

Rats reach sexual maturity at approximately nine weeks of age.

Females can give birth to six litters per year, an average of five to ten offspring each.

This rapid reproduction rate can cause populations to rebound quickly after implementing a lethal control program.

Rat behavior, either learned or innate, can negatively affect pest control efforts.

Under ideal conditions, a female rat can yield up to 15,000 descendants in approximately 12 months.

Lethal control measures such as traps and rodenticides are often at the forefront of rat control programs.

However, this reproduction rate, along with intelligence and genetic resistance to the active ingredients in rodenticides, can negatively impact results of traditional mitigation efforts.

Rodents reach sexual maturity between approximately six to nine weeks of age.

Female rats can give birth to six litters per year with an average of five to ten offspring each.

Female mice can produce up to ten litters per year with an average of five to six offspring.

This prolific breeding can cause populations to rebound quickly even after implementing a lethal control program.

Rodent behavior, either learned or innate, can negatively affect pest control efforts.

Neophobia, or the fear and avoidance of new objects, is an innate behavior that often impacts control efforts.

Rats avoid bait stations, loose bait, or traps until they are confident that these new objects pose no danger.

Over time rats will begin to sample new foods to determine if there are any negative side effects.

If the food or rodenticide causes illness in rats but they do not die, they will avoid that food or rodenticide in the future.

Rodents will sample new foods and baits to establish palatability and determine if there are any negative side effects, which reduces the likelihood of ingesting a lethal dose of rodenticide.

If the rodenticide causes illness in rodents but they survive, they will develop conditioned aversion and avoid such substance in the future.

Resistance to traditional rodenticides creates challenges for rodent control programs.

Rats, like all animals, are hard-wired to survive and some rats can be born with a genetic mutation making them resistant to certain rodenticides.

Studies show that resistance is increasing in rat species.

This resistance is passed onto their offspring who will then carry this resistant trait into future generations.

Because of the above factors, traditional rodenticide producers are continually challenged to develop new, more lethal chemicals to control future rat populations.

Rodenticides may affect other species within the food chain.

It has been reported that animals that prey on rats such as raptors, large cats, foxes, and other mammals of concern have significant levels of rodenticide present in their bodies due to persistence of the rodenticide in the rat tissue, which may also result in contamination of the food supply.

Rodents, like all animals, are hard-wired to survive.

Further, some rats can be born with a genetic mutation making them resistant to certain rodenticides.

Studies show that resistance is increasing in commensal rodents as resistance can be passed onto offspring who will then carry this resistant trait into future generations.

Because of these factors, traditional rodenticide producers are continually challenged to develop new, more lethal chemicals to control future rat populations.

Rodenticides do not just affect their intended target but can also directly impact other species or transfer through the food chain.

Animals that prey or scavenge on poisoned rats such as raptors, large cats, foxes, and other mammals of concern have significant levels of rodenticide present in their bodies due to persistence of the rodenticide in the rat tissue.

The Center for Biological Diversity highlights that rodenticides can be lethal to any bird or mammal and their non-selective toxicity endangers various wildlife species.

The United States Geological Survey notes that despite regulatory efforts to limit certain rodenticides, exposure and adverse effects in non-target predatory wildlife persist, indicating ongoing environmental risks.

Additionally, there is growing concern about the rise in reported cases of adverse effects that rodenticides have on children and pets due to accidental, direct exposure.

In November 2022, the EPA released an update to its Endangered Species Act workplan which intends to expand the mitigation efforts for 90 species potentially affected by rodenticides.

The EPA will perform biological evaluations to analyze the potential effects of the rodenticides on listed species and their designated critical habitats and will identify mitigation measures for these species and critical habitats to avoid or minimize exposure from the rodenticides.

When the plan is described, they will consider it the Rodenticide Strategy.

A portion of the draft plan includes a focus on addressing effects to primary consumers of rodenticide bait (mammals and birds) and to secondary consumers that consume primary consumers (mammals, birds, and reptiles).

These changes to the EPA’s review and registration policies could affect filings with the agency due to expanded test requirements for mammals, birds, reptiles, and critical habitats.

Even though ContraPest is not a traditional rodenticide, these requirements (or a subset) may impact our registration in the future since it is classified in the rodenticide category with the EPA.

We will maintain

close contact with the EPA as their final guidance with respect to this policy was released in December 2023 with an intended final biological evaluation due November 2024.

The American Society for the Prevention of Cruelty to Animals (“ASPCA”) reports that these substances are highly toxic to cats and dogs leading to severe health issues such as internal bleeding, kidney failure, seizures, or even death.

Studies show that anticoagulant rodenticides are the most reported substance causing pet poisonings.

The American Association of Poison Control Centers reported the number of human cases between

2011 and 2015 was a cumulative total of 44,095 and 1,029 for long-acting superwarfarin-type and warfarin-type drugs, respectively, and 88% of these involved children under the age of five.

In addition to direct exposure to humans, chemicals in rodenticides have also been found as contaminates in the food supply.

In November 2022, the EPA announced an update to its Endangered Species Act of 1973 (“ESA”) Workplan to expand the protection efforts for endangered species potentially affected by rodenticides.

In November 2024, the EPA released its final Biological Evaluations for 11 rodenticide active ingredients, assessing their potential effects on approximately 90 endangered species and their critical habitats.

These evaluations guide regulatory actions and implement mitigation measures to restrict or condition rodenticide use in areas where endangered species may be present to reduce exposure risks.

Such measures include specifying distances between rodenticide application sites and critical habitat to create buffer zones, restricting application by limiting how and where rodenticides can be applied, and requiring training and certification for applicators that ensures safe and targeted use.

In addition, they require rodenticide label updates to reflect new usage restrictions, mitigation measures and environmental protection guidelines, which can alter market preference to shift toward more attractive, non-lethal solutions.

Changes to the EPA’s review and registration policies could affect filings with the agency due to expanded test requirements for mammals, birds, reptiles, and critical habitats.

ContraPest is not a traditional rodenticide and does not contain the active ingredients under this evaluation.

While these requirements (or a subset) do not directly impact our registration, ContraPest is classified in the rodenticide category with the EPA, therefore, updates to ContraPest’s current registration or newly registered products with the agency in the future may be subject to stricter testing requirements or limitations on use.

However, ContraPest, under its current registration, and the exemption status of Evolve as a 25b pesticide, offers a distinct competitive advantage in the rodent control market through its alternative non-lethal and environmentally benign products.

Integrated Pest Management and Fertility Control

The most effective, long-term way to manage rats is by using a combination of tools that work together to magnify the efficacy of the pest management protocol;

The most effective, long-term way to manage rodents is by using a combination of tools that work together to magnify the efficacy of the pest management protocol;

IPM is based upon this concept.

An effective IPM program needs to reduce the existing rat population while preventing the population from rebounding.

The EPA defines IPM as an effective and environmentally sensitive approach to pest management that relies on a combination of common-sense practices through use of current, comprehensive information on the life cycles of pests and their interaction with the environment.

This approach considers the least hazardous and most economical option to people, property, and the environment.

An effective IPM program should reduce the existing rat population, while preventing recurrence of the problem thus limiting continual application of hazardous chemicals such as lethal rodenticides.

Based on company field research, the addition of a fertility control product to an IPM program has demonstrated improved efficacy of more than 90% with sustained population suppression.

Maintaining a fertility control program reduces the reproduction and therefore the risk of future population spikes, known in the industry as the rebound effect.

A fertility control program reduces the reproduction and therefore the risk of future population spikes, known in the industry as the rebound effect.

Fertility control can also trigger the Allee Effect, which means that when a population becomes too small, it struggles to survive.

This happens because it becomes harder for individuals to find mates and to reproduce.

As a result, the population declines even faster, helping suppress or even eliminate it.

Accordingly, fertility control can reduce the reliance on poisons or their frequency of use, allowing for a pest control program that focus on maintenance only.

Updates to the EPA’s ESA Workplan in November 2024 strongly encourage a shift towards IPM that promotes alternatives to rodenticides, including non-lethal and environmentally safer solutions.

This shift aligns with our fertility control products, ContraPest and Evolve.

The EPA has indicated a willingness to collaborate with manufacturers and stakeholders to ensure compliance and explore safer alternatives given the recent ESA changes.

As the first and only EPA registered liquid contraceptive bait for use on Norway rat and roof rat populations, ContraPest was – and remains – a novel product among a catalog of lethal rodenticides that have dominated the market.

The EPA granted us waivers for several studies typically required for new rodenticide products at the time ContraPest was initially registered because of its low risk profile and use characteristics.

While there may be limitations to how and where ContraPest can be used, ContraPest’s product features align with the agency’s agenda to provide alternative IPM solutions and allows us the potential opportunity to further expand our partnerships.

company studies)

4 unchanged sentences

We believe that the size of the rat control market is sufficient for our near-term focus.

We remain open to the potential to license our technology to other strategic partners to explore its applicability to other mammalian species.

We remain open to potentially to licensing our technology for our strategic partners to explore its applicability to other mammalian species.

Business Strategy

2 unchanged sentences

End User Awareness and Adoption.

Our focus is educating end users on the rapid reproduction rate of rats, which draws attention to the complex issue of gaining control of an infestation if you do not have control of rat fertility.

As more rodenticides come to market to address rat populations, attention will be drawn to the impact other rodenticides may have to other species due to bioaccumulation, and the benefit of ContraPest and Evolve having a low potential for bioaccumulation.

Our focus is educating end users on the rapid reproduction rate of rodents, which draws attention to the complex issue of gaining control of an infestation when you do not have control of fertility.

As more rodenticides come to market to address rat populations, attention will be drawn to the impact other rodenticides may have on other species due to bioaccumulation, and the benefit of ContraPest and Evolve having a low potential for bioaccumulation.

Our fertility control products align with the EPA’s recent push for non-lethal alternatives and reduced environmental impact.

Tailored Value Propositions.

7 unchanged sentences

• Efficiencies.

Through securing more reliable, affordable suppliers for our raw materials, and continuous development of our manufacturing process, we will be able to increase profits while scaling to meet rising product demand, and production of additional registered products.

Through securing more reliable, affordable suppliers for our raw materials, and continuous development of our manufacturing process, we will be able to increase profits while scaling production to meet rising product demand and the production of additional registered products.

Marketing and Sales Approach

ContraPest is differentiated in what is otherwise a very crowded pest control market.

It is the only product registered with the EPA that restricts fertility in both male and female rats and is designed to be non-lethal.

As first and second generation anti-coagulants come under increased scrutiny for non-target accidental consumption or for bioaccumulation with impact on non-target species as rodenticides travel up the food chain, their use is being restricted or even banned in select areas across the United States and globally.

These increasing restrictions and bans create an opportunity for ContraPest, as industry professionals are looking for effective tools to serve their customers and gain control of rat populations through nontraditional means.

Like ContraPest, Evolve is also differentiated in the pest control market due to its unique approach to restrict fertility in rats as opposed to other lethal means.

In addition, Evolve meets the EPA’s FIFRA Section 25(b) minimum risk pesticide conditions.

Evolve is exempt from federal registration because it poses little to no risk to human health and the environment and is made from food ingredients, within tolerances of exemption for both food and nonfood applications, which allows it to be used in agricultural applications.

Because the pest industry in the United States has demonstrated a reluctance to adopt new technologies, the marketing of fertility control has primarily been aimed at end-user awareness, creating pull through demand with Pest Management Providers (“PMP”) by applying pressure for PMPs to use fertility control as part of their IPM.

Additionally, within our target verticals, agribusiness, commercial, distributors, e-commerce, pest management, municipalities, and zoos and sanctuaries, many large targets employ internal pest management teams as opposed to contracting with service providers.

For these reasons, the end-user is our primary target in order to grow market penetration for fertility control products.

ContraPest and Evolve are differentiated in what is otherwise a very crowded pest control market.

They are the only products registered with or exempt from registration by the EPA that restrict fertility in both male and female rats and are designed to be non-lethal.

As first and second generation anti-coagulant rodenticides come under increased scrutiny for non-target exposure and bioaccumulation impacts on non-target species as they travel up the food chain, their use is being restricted or banned in select areas across the United States and globally.

These increasing restrictions and bans create an opportunity to highlight the safety and efficacy of our products as industry professionals look for alternative tools to serve their customers and gain control of rat and mouse populations through nontraditional means.

Because the pest industry in the United States has demonstrated a reluctance to adopt new technologies, the marketing of fertility control has primarily been aimed at end-user and professional awareness, and penetration of the key verticals of agribusiness distribution, pest management distribution, industrial distribution, retail distribution, international distribution and e-commerce.

While pain points and benefits are unique to each vertical, they have shared core value propositions.

4 unchanged sentences

• Fertility control can be used as an anchor or enhancement for an IPM program, and as a solution to decrease reliance on poisons or other lethal control options.

Three core sales channels drive revenue allowing SenesTech to reach a wider customer base and target different segments of the market.

• e-Commerce.

E-commerce provides a hub to push end-users for further education as well as providing 24/7 availability for purchasing products and managing subscriptions.

• Field Sales.

Field sales allow for personal interaction, consultation, and development of potential customers.

Field sales representatives, in charge of regional territories across the United States, focus in the larger account segments, attending trade shows and educational opportunities within target verticals.

• Distributors and resellers.

Distributors and resellers serve as an expansion of our sales team, increasing our reach by leveraging the established networks and connections of these third-party businesses.

Additionally, the logistics and marketing support offered through these partners reduces cost and effort required to expand our sales.

Raw Materials and Manufacturing Process

The Evolve products contain one active ingredient, cottonseed oil, a plant-derived food product.

Evolve also contains several other inactive food ingredients.

Currently, we source cottonseed oil from standard food suppliers, and it is available from a variety of sources.

Our manufacturing process for Evolve involves the incorporation of our active ingredient, in low concentration, into several inactive ingredients.

Once incorporated, the entire product is packaged inside of a casing and cut to length for sale.

This process allows Evolve to be delivered to rats and mice in a palatable, effective manner, and it is designed to be non-lethal.

ContraPest contains two active ingredients, VCD, an industrial chemical, and triptolide, a plant derived chemical.

ContraPest also contains several other inactive, generally recognized as safe (“GRAS”), ingredients.

ContraPest also contains several other inactive, generally recognized as safe, ingredients.

Currently, we source VCD from standard industrial chemical supply providers.

Triptolide is derived from the Thunder god vine, Tripterygium wilfordii, which is commonly cultivated and harvested wild in southeastern China and other Asian countries.

Triptolide is

available from a variety of sources, but the process to purify triptolide for use in ContraPest is expensive.

Triptolide is available from a variety of sources, but the process to purify triptolide for use in ContraPest is expensive.

Thus, we are investigating other, less costly sources of triptolide.

2 unchanged sentences

This process allows ContraPest to be delivered to rats in a palatable, effective manner, and it is designed to be non-lethal.

Evolve contains one active ingredient, cottonseed oil, a plant-derived food product.

Evolve also contains several other inactive food ingredients.

Currently, we source cottonseed oil from standard food suppliers, and it is available from a variety of sources.

Our manufacturing process for Evolve involves the incorporation of our active ingredient, in low concentration, into several inactive ingredients.

Once incorporated, the entire product is packaged inside of a casing and cut to length for sale.

This process allows Evolve to be delivered to rats in a palatable, effective manner, and it is designed to be non-lethal.

Currently, we have production scale capability in our facilities in Arizona to manufacture ContraPest and Evolve.

Our internal production capabilities allow us to meet our current and anticipated demand through 2024.

Our internal production capabilities allow us to meet our current and anticipated demand through 2025 and beyond.

Scientific Background Regarding our Product

12 unchanged sentences

Other Potential Products

We have begun work on the application of ContraPest and Evolve on other species, such as mice, and expect to introduce an additional product during 2024.

We continue to explore the application of ContraPest and Evolve on other species.

We expect to continuously evaluate and evolve our current product offerings and, technology and market conditions permitting, introduce additional products.

Currently, we are unaware of any other non-lethal fertility control products targeting rats that are registered by the EPA.

1 unchanged sentence

We do not believe these to be competitive products.

Our principal competition are large corporations with greater resources that offer a wider range of products.

Generally, these are lethal pest control products largely consisting of rodenticide-based products and other tools that PMPs use in their IPM.

Our principal competition is large corporations with greater resources that offer a wider range of products.

Generally, these are lethal pest control products largely consisting of rodenticide-based products and other tools that Pest Management Provider (“PMPs”) use in their IPM.

Government Regulation and Product Approval

3 unchanged sentences

In the United States, the EPA regulates the sale, distribution and use of any pesticide under FIFRA.

The EPA’s definition of a pesticide includes “any substance or mixture of substances intended for preventing, destroying, repelling, or mitigating any pest.” FIFRA defines a pest as “any insect, rodent, nematode, fungus, or weed.” To register a new product with the EPA, all active ingredients within the product must be registered with the EPA.

The EPA has an exemption under FIFRA, Section 25(b) which exempts certain pesticides from federal registration based on six criteria for minimum risk.

Evolve is exempt from registration as a minimum risk pesticide under FIFRA, Section 25(b).

All applicable requirements for registration, manufacturing, selling, or distributing into designated sates and territories have been met.

Evolve has not been registered by the EPA but is in the process of registering in all 50 states, the District of Columbia, and five major U.S.

There are 10 states that accept the federal exemption for pesticide registration within the respective state.

For the states that do not accept the federal exemption, we began the registration process for pesticide registration in October 2023.

To date, we are authorized to sell Evolve in 48 states.

The EPA granted registration for ContraPest effective August 2, 2016, and as of July 12, 2018, we have received registration for ContraPest in all 50 states, the District of Columbia, and five major U.S.

This initial EPA approval labeled ContraPest as a restricted-use product, due to the need for applicator expertise for deployment.

On October 18, 2018, the EPA removed the Restricted Use designation, meaning that we can sell ContraPest to consumers who do not have applicator expertise.

On October 18, 2018, the EPA removed the Restricted Use designation, meaning that we can sell ContraPest to consumers

who do not have applicator expertise.

ContraPest is currently limited by EPA requirements to indoor use and to use within one foot of manmade structures.

We intend to diligently pursue additional related regulatory approvals from the EPA to support our product evolution, including seeking approval for full outdoor use, alternative formulations and for additional rodent species.

This may entail the need to complete and submit to EPA additional studies, principally related to the effects on other animals and fish if ingested or if the product enters the water supply.

In addition to the EPA registration of ContraPest in the United States, we must obtain registration from the various state regulatory agencies prior to selling in each state.

4 unchanged sentences

In certain cases, our EPA and state registrations require completion of testing and certifications even after we have received approval for the product or its labeling.

We continue to seek to comply with these requirements.

The EPA has an exemption under FIFRA, Section 25(b) which exempts certain pesticides from federal registration based on six criteria for minimum risk.

Evolve qualifies from registration as a minimum risk pesticide under FIFRA, Section 25(b).

All applicable requirements for registration, manufacturing, selling, or distributing into designated sates and territories have been met.

Evolve has not been registered by the EPA but is in the process for registration in all 50 states, the District of Columbia, and five major U.S.

There are 10 states that accept the federal exemption for pesticide registration within the respective state.

For those states that do not accept the federal exemption, we began the registration process for those states in October 2023.

To date, we are authorized to sell Evolve in 30 states.

We continue to seek compliance with these requirements.

International Review and Approval Processes

We are researching potential international markets and will evaluate the regulatory landscapes of each prospective market.

With the assistance of in-country distributors, we are pursuing potential international markets and evaluating the regulatory landscapes of each prospective market.

Country-specific regulatory laws have provisions that include requirements for certain labeling, safety, efficacy and manufacturers’ quality control procedures to assure the consistency of the product, as well as company records and reports.

1 unchanged sentence

As of December 31, 2024, we had 23 full-time employees and no part-time employees.

Within our workforce, eight employees are engaged in research and development and 17 employees are engaged in sales, business development, finance, regulatory, human resources, facilities, information technology and general management and administration.

Within our workforce, 11 employees are engaged in manufacturing, quality assurance and research and development and 12 employees are engaged in sales, business development, finance, regulatory, human resources, facilities, information technology, and general management and administration.

None of our employees are represented by labor unions or covered by collective bargaining agreements.

Intellectual Property and Other Proprietary Rights

Maintaining a strong position in the rodenticide market requires constant innovation along with a healthy research program to evolve product lines to remain competitive and relevant to the needs of the changing global marketplace.

Maintaining a strong position in the rodenticide market requires constant innovation along with a healthy research program to evolve product lines in order to remain competitive and relevant to the needs of the changing global marketplace.

We seek to protect our proprietary data and trade secrets with attention to data exchanges among employees, consultants, collaborators and research and trade partners.

16 unchanged sentences

The EPA rules do not describe how the compensation should be determined, and there is publicly available information about some, but not all, binding arbitration decisions.

Incorporation and Capital Structure

We were originally incorporated in the State of Nevada in July 2004, and on November 12, 2015, we reincorporated in the State of Delaware.

Our corporate headquarters and manufacturing site are in Phoenix, Arizona.

On December 8, 2016, we went public and are currently traded on the Nasdaq under the symbol SNES.

In July 2024, we amended our Amended and Restated Certificate of Incorporation to effect a 1-for-10 reverse split of our issued and outstanding shares of common stock.

The accompanying financial statements and notes thereto provide retrospective effect to the reverse stock split for all periods presented.

Where You Can Find Additional Information

3 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 1. Business